The carrier screening market was valued at $1,378.06 million in 2020, and is projected to reach $4,002.05 million by 2030, growing at a CAGR of 11.5% from 2021 to 2030.
Genetic testing is known as carrier screening, which is performed on people who display no symptoms for a genetic disorder but may be at risk for passing it on to next generation or potentially may develop the disease later in their life. A carrier for a genetic disorder is inherited from one normal and one abnormal allele for a gene associated with the disorder. The only time people find out that they are the carrier of a specific genetic disorder is when they have an affected child. In addition, the market growth is attributed to surge in incidence of genetic diseases, increase in availability & affordability of tests, and rise in number of advanced product launches. Moreover, large biotechnology firms all over the world are increasingly focusing on acquiring companies that provide solutions for the tests, which is expected to notably contribute toward the market growth.
Furthermore, the global carrier screening market growth is largely driven by factors such as significant applications of carrier screening in genetic disorder fields, various initiatives & funding from government & private bodies for large-scale carrier screening projects, and decline in cost of screening. Prominent players in the global carrier screening market have opted various strategies such as product launches, acquisition, and investments in R&D for advancement in carrier screening to strengthen their position in the market and sustain the competitive environment.
Alarming increase in prevalence of fetal chromosomal abnormalities and genetic disorders across the globe is one of the key factors driving the growth of the market. However, dearth of highly skilled professionals restricts the market growth. Conversely, various technological advancements such as the development of next-generation sequencing (NGS) techniques for genetic disease screening and DNA sequencing are expected to provide lucrative opportunities for the growth of the market in near future. Extensive R&D activities in the field of biotechnology and bioinformatics along with significant improvement in medical infrastructure are anticipated to open new avenues for the expansion of the market.
The growth of the global carrier screening market is segmented into type, technology, end user, and region. By type, the market is classified into expanded carrier screening and targeted disease carrier screening. The expanded carrier screening segment is further dived into customized panel testing and predesigned panel testing. On the basis of technology, the market is categorized into DNA sequencing, polymerase chain reaction, microarrays, and other technologies. The end users covered in the study include hospitals & clinics, reference laboratories, physician offices, and others. Region wise, the market is thoroughly analyzed across North America, Europe, Asia-Pacific, and LAMEA.
This report provides comprehensive competitive analysis and profiles of prominent market players such as Eurofins Scientific, Invitae Corporation, Opko Health, Fulgent Genetics Inc., Quest Diagnostics Incorporated, Natera Inc. Myriad Genetics, Illumina Inc., Thermo Fisher Scientific Inc., and Luminex Corporation.
Genetic testing is known as carrier screening, which is performed on people who display no symptoms for a genetic disorder but may be at risk for passing it on to next generation or potentially may develop the disease later in their life. A carrier for a genetic disorder is inherited from one normal and one abnormal allele for a gene associated with the disorder. The only time people find out that they are the carrier of a specific genetic disorder is when they have an affected child. In addition, the market growth is attributed to surge in incidence of genetic diseases, increase in availability & affordability of tests, and rise in number of advanced product launches. Moreover, large biotechnology firms all over the world are increasingly focusing on acquiring companies that provide solutions for the tests, which is expected to notably contribute toward the market growth.
Furthermore, the global carrier screening market growth is largely driven by factors such as significant applications of carrier screening in genetic disorder fields, various initiatives & funding from government & private bodies for large-scale carrier screening projects, and decline in cost of screening. Prominent players in the global carrier screening market have opted various strategies such as product launches, acquisition, and investments in R&D for advancement in carrier screening to strengthen their position in the market and sustain the competitive environment.
Alarming increase in prevalence of fetal chromosomal abnormalities and genetic disorders across the globe is one of the key factors driving the growth of the market. However, dearth of highly skilled professionals restricts the market growth. Conversely, various technological advancements such as the development of next-generation sequencing (NGS) techniques for genetic disease screening and DNA sequencing are expected to provide lucrative opportunities for the growth of the market in near future. Extensive R&D activities in the field of biotechnology and bioinformatics along with significant improvement in medical infrastructure are anticipated to open new avenues for the expansion of the market.
The growth of the global carrier screening market is segmented into type, technology, end user, and region. By type, the market is classified into expanded carrier screening and targeted disease carrier screening. The expanded carrier screening segment is further dived into customized panel testing and predesigned panel testing. On the basis of technology, the market is categorized into DNA sequencing, polymerase chain reaction, microarrays, and other technologies. The end users covered in the study include hospitals & clinics, reference laboratories, physician offices, and others. Region wise, the market is thoroughly analyzed across North America, Europe, Asia-Pacific, and LAMEA.
This report provides comprehensive competitive analysis and profiles of prominent market players such as Eurofins Scientific, Invitae Corporation, Opko Health, Fulgent Genetics Inc., Quest Diagnostics Incorporated, Natera Inc. Myriad Genetics, Illumina Inc., Thermo Fisher Scientific Inc., and Luminex Corporation.
KEY BENEFITS FOR STAKEHOLDERS
- The study provides an in-depth analysis of the global carrier screening market along with the current trends and future estimations to elucidate the imminent investment pockets.
- A comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.
- Comprehensive quantitative analysis of the industry from 2020 to 2030 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
- Extensive analysis of the key segments of the industry helps to understand the products and end users of carrier screening used across the globe.
- Key market players and their strategies have been analyzed to understand the competitive outlook of the market.
KEY MARKET SEGMENTS
By Type
- Expanded Carrier Screening
- Customized Panel Testing
- Predesigned Panel Testing
- Targeted Disease Carrier Screening
By Technology
- DNA Sequencing
- Polymerase Chain Reaction
- Microarrays
- Other Technologies
By End User
- Hospitals & Clinics
- Reference Laboratories
- Physician Offices
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- Spain
- Italy
- UK
- Rest of Europe
- Asia-Pacific
- Australia
- Japan
- India
- China
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
KEY MARKET PLAYERS
- Eurofins Scientific
- Invitae Corporation
- Opko Health
- Fulgent Genetics Inc.
- Quest Diagnostics Incorporated
- Natera Inc.
- Myriad Genetics
- Illumina Inc.
- Thermo Fisher Scientific Inc.
- Luminex Corporation
Frequently Asked Questions about the Carrier Screening Market
What is the estimated value of the Carrier Screening Market?
What is the growth rate of the Carrier Screening Market?
What is the forecasted size of the Carrier Screening Market?
Who are the key companies in the Carrier Screening Market?
| Report Attribute | Details |
|---|---|
| No. of Pages | 361 |
| Published | October 2021 |
| Forecast Period | 2020 - 2030 |
| Estimated Market Value ( USD | $ 1378.06 million |
| Forecasted Market Value ( USD | $ 4002.05 million |
| Compound Annual Growth Rate | 11.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 9 |
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET LANDSCAPE
CHAPTER 4: CARRIER SCREENING MARKET, BY TYPE
CHAPTER 5: CARRIER SCREENING MARKET, BY TECHNOLOGY
CHAPTER 6: CARRIER SCREENING MARKET, BY END USER
CHAPTER 7: CARRIER SCREENING MARKET, BY REGION
CHAPTER 8: COMPANY PROFILES
List of Tables
List of Figures
Companies Mentioned
- Eurofins Scientific
- Invitae Corporation
- Opko Health
- Fulgent Genetics Inc.
- Quest Diagnostics Incorporated
- Natera Inc. Myriad Genetics
- Illumina Inc.
- Thermo Fisher Scientific Inc.
- Luminex Corporation
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
